Início › Câncer de Ovário › Flórida

Ensaios clínicos de Câncer de Ovário em Flórida

81 estudos para Câncer de Ovário estão buscando participantes em locais em Flórida.

Cidades em Flórida

Texto oficial do estudo (Inglês)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
e mais 6

RecrutandoFase 2

Todas as idades · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of Miami - Sylvester Comprehensive Cancer Center, Miami
Advent Health, Orlando
Florida Cancer Specialists South, Port Charlotte

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus, Fort Myers

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06760819

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

AdventHealth Cancer Institute, Orlando

RecrutandoFase 1

Idades 19 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06586957

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

AdventHealth Medical Group Oncology Research at Celebration, Kissimmee

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06172478

Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer

Research Site, Tampa

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 1 de out. de 2026 · NCT07851025

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Mayo Clinic in Florida, Jacksonville

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07285044

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

Florida Cancer Specialists, Sarasota

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06799065

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, Jacksonville

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05877599

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Site 0241 - Florida Cancer Specialist - North, Altamonte Springs
Site 0173 - Mount Sinai Medical Center, Miami Beach
Site 0308 - Advent Health, Orlando
e mais 1

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 29 de set. de 2026 · NCT05128825

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Jupiter Medical Center /ID# 276616, Jupiter
Mount Sinai Medical Center /ID# 274868, Miami Beach

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 29 de set. de 2026 · NCT06890338

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Mayo Clinic, Jacksonville
Genoma Research, Inc., Miami
Orlando Health, Orlando
e mais 1

RecrutandoEstudo observacional

Idades 18 e acima · Mulheres · Atualizado em 29 de set. de 2026 · NCT05051722

Study of AVZO-021 in Patients With Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site, Sarasota
Avenzo Therapeutics Recruiting Site, Tampa

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05867251

DESTINY-PANTUMOUR04

Research Site, Coral Springs
Research Site, St. Petersburg
Research Site, West Palm Beach

RecrutandoEstudo observacional

Idades de 18 a 130 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07124000

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Mayo Clinic Jacksonville, Jacksonville
Moffitt Cancer Center, Tampa

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT04981119

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Florida Cancer Specialists, Sarasota
Moffitt Cancer Center and Research Institute, Tampa

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06128551

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

University of Florida College of Medicine /ID# 278348, Gainesville
Orlando Health Cancer Institute Gynecologic Cancer Center - Orlando /ID# 278623, Orlando
Florida Cancer Specialists - North /ID# 278626, St. Petersburg
e mais 1

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 22 de set. de 2026 · NCT07059845

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Broward Health Medical Center, Fort Lauderdale
Florida Cancer Specialist- South, Fort Myers
Baptist MD Anderson Cancer Center, Jacksonville
e mais 5

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Moffitt, Tampa

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07213791

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Sylvester Comprehensive Cancer Center, Miami
Sara Cannon Research Institute Lake Nona, Orlando
Hematology - Oncology Associates of the Treasure Coast, Port Saint Lucie

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT05983432

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Florida Cancer Specialists - Lake Nona, Orlando

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07109726

Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer

Moffitt Cancer Center, Tampa

RecrutandoFase 1

Idades 18 e acima · Mulheres · Atualizado em 17 de set. de 2026 · NCT05316129

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

Mount Sinai Cancer Center ( Site 0029), Miami Beach
Orlando Health Winnie Palmer Hospital for Women and Babies ( Site 0085), Orlando

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 17 de set. de 2026 · NCT07318558

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

Moffitt Cancer Center, Tampa

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07487168

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

Advent Health, Orlando

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 15 de set. de 2026 · NCT06915025

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Florida Cancer Specialists & Research Institute, Fort Myers
Sylvester Comprehensive Cancer Center, Miami
Mount Sinai Comprehensive Cancer Center, Miami Beach
e mais 1

RecrutandoFase 2

Idades de 18 a 99 · Mulheres · Atualizado em 15 de set. de 2026 · NCT07023627

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Brcr Global, Miramar
Sarasota Memorial Health Care System, Sarasota

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 15 de set. de 2026 · NCT07214779

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Cleveland Clinic Foundation - Florida, Weston

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 14 de set. de 2026 · NCT04575935

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

Mayo Clinic Jacksonville, Jacksonville
University of Miami Sylvester Comprehensive Cancer Center, Miami
Advent Health Cancer Institute, Orlando
e mais 1

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 14 de set. de 2026 · NCT06787612

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Memorial Healthcare System, Hollywood
The Oncology Institute of Hope & Innovation, Lakeland

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

University of Miami, Miami
Sarah Cannon Research Institute - Lake Nona Florida, Orlando

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT06293898

Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

Mt. Sinai Comprehensive Cancer Center, Miami
Sarasota Memorial Health Care System, Sarasota

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 9 de set. de 2026 · NCT07225270

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando

RecrutandoFase 1

Idades 18 e acima · Mulheres · Atualizado em 3 de set. de 2026 · NCT07755436

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Mount Sinai Braman Comprehensive Cancer Center ( Site 0078), Miami Beach
Sarasota Memorial Hospital ( Site 0075), Sarasota
Florida Cancer Specialists East ( Site 7000), West Palm Beach

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 3 de set. de 2026 · NCT06824467

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

Florida Cancer Specialists, Orlando

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT07186842

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

AdventHealth Cancer Institute, Orlando
Sarasota Memorial Healthcare System, Sarasota
Women's Cancer Associates with Women's Care Florida, St. Petersburg

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 26 de ago. de 2026 · NCT05281471

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Moffitt Cancer Center, Tampa

RecrutandoFase 1

Idades 15 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT06276491

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

UF Health Cancer Institute - Gainesville, Gainesville

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT07001748

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

SCRI - Florida Cancer Specialists, Sarasota

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07470853

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
Florida Cancer Specialists - Bradenton Cancer Center, Bradenton
Morton Plant Hospital, Clearwater
e mais 25

Recrutando

Idades de 35 a 50 · Mulheres · Atualizado em 7 de ago. de 2026 · NCT04251052

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.